ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
0.00%
US Dollar vs MXN
16.5398
-0.09%
Brent Oil
82.345
-1.42%
Bitcoin
71,356.78
-0.13%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAXU)

  7. Phoenix Biotech Aquisition Corporation (PBAXU) Noticias

PBAXU Phoenix Biotech Aquisition Corporation

10.37
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Phoenix Biotech Aquisition Corporation PBAXU NASDAQ CKDES
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 10.37 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
10.37
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/5/202416:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/5/202405:28EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
06/5/202416:11EDGAR2Form S-1 - General form for registration of securities under..
03/5/202415:30EDGAR2Form 8-K - Current report
01/5/202423:16EDGAR2Form EFFECT - Notice of Effectiveness
01/5/202415:45EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/5/202415:13EDGAR2Form 8-K - Current report
26/4/202415:31EDGAR2Form S-1/A - General form for registration of securities..
15/4/202415:36EDGAR2Form DEF 14A - Other definitive proxy statements
10/4/202415:06EDGAR2Form S-1 - General form for registration of securities under..
03/4/202416:27EDGAR2Form PRE 14A - Other preliminary proxy statements
02/4/202406:12EDGAR2Form 8-K/A - Current report: [Amend]
02/4/202406:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/4/202420:54EDGAR2Form NT 10-K - Notification of inability to timely file Form..
27/3/202420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/3/202420:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:00EDGAR2Form 8-K - Current report
27/2/202407:27EDGAR2Form 8-K/A - Current report: [Amend]
20/2/202416:18EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202418:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202411:14EDGAR2Form 425 - Prospectuses and communications, business..
14/2/202411:12EDGAR2Form 8-K - Current report
12/2/202415:16EDGAR2Form 425 - Prospectuses and communications, business..
12/2/202415:14EDGAR2Form 8-K - Current report
06/2/202405:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/2/202405:14EDGAR2Form 425 - Prospectuses and communications, business..
06/2/202405:11EDGAR2Form 8-K - Current report
22/1/202416:29EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/1/202416:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/1/202415:08EDGAR2Form 425 - Prospectuses and communications, business..
05/1/202415:05EDGAR2Form 8-K - Current report
14/12/202315:37EDGAR2Form DEF 14A - Other definitive proxy statements
11/12/202316:07EDGAR2Form 425 - Prospectuses and communications, business..
11/12/202316:04EDGAR2Form 8-K - Current report
27/11/202315:02EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/9/202315:35EDGAR2Form 425 - Prospectuses and communications, business..
08/9/202315:31EDGAR2Form 8-K - Current report
14/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/7/202307:33EDGAR2Form S-4/A - Registration of securities, business..
18/7/202315:06EDGAR2Form 425 - Prospectuses and communications, business..
18/7/202315:05EDGAR2Form 8-K/A - Current report: [Amend]
10/7/202316:15EDGAR2Form 425 - Prospectuses and communications, business..
10/7/202316:12EDGAR2Form 8-K - Current report
03/7/202312:14EDGAR2Form 425 - Prospectuses and communications, business..
03/7/202312:11EDGAR2Form 8-K - Current report
03/7/202312:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

Su Consulta Reciente

NASDAQ
PBAXU
Phoenix Biotech Aquisition
LSE
COT
ASX
LAWNA
LawFinance
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados